BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 1451593)

  • 1. Neutrophil function screening in patients with chronic granulomatous disease by a flow cytometric method.
    Epling CL; Stites DP; McHugh TM; Chong HO; Blackwood LL; Wara DW
    Cytometry; 1992; 13(6):615-20. PubMed ID: 1451593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier screening and prenatal detection of chronic granulomatous disease in Iran.
    Ayatollahi M; Geramizadeh B
    Saudi Med J; 2006 Sep; 27(9):1334-7. PubMed ID: 16951769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitroblue tetrazolium slide test. Use of the phorbol-myristate-acetate-stimulated NBT-reduction slide test for routine and prenatal detection of chronic granulomatous disease and diagnosis of heterozygous carriers.
    Johansen KS
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):349-54. PubMed ID: 6673503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions.
    Emmendörffer A; Nakamura M; Rothe G; Spiekermann K; Lohmann-Matthes ML; Roesler J
    Cytometry; 1994 Sep; 18(3):147-55. PubMed ID: 7813334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and carrier detection of chronic granulomatous disease in five families by flow cytometry.
    Crockard AD; Thompson JM; Boyd NA; Haughton DJ; McCluskey DR; Turner CP
    Int Arch Allergy Immunol; 1997 Oct; 114(2):144-52. PubMed ID: 9338608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fast and easy nitroblue tetrazolium method for carrier screening and prenatal detection of chronic granulomatous disease.
    Ayatollahi M; Tabei Z; Ramzi M; Kashef S; Haghshenas M
    Arch Iran Med; 2006 Oct; 9(4):335-8. PubMed ID: 17061605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes.
    Vowells SJ; Sekhsaria S; Malech HL; Shalit M; Fleisher TA
    J Immunol Methods; 1995 Jan; 178(1):89-97. PubMed ID: 7829869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
    J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric evaluation of nitro blue tetrazolium (NBT) reduction in human polymorphonuclear leukocytes.
    Fattorossi A; Nisini R; Le Moli S; De Petrillo G; D'Amelio R
    Cytometry; 1990; 11(8):907-12. PubMed ID: 2272251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phorbol myristate acetate stimulated NBT test: a simple method suitable for antenatal diagnosis of chronic granulomatous disease.
    Levinsky RJ; Harvey BA; Rodeck CH; Soothill JF
    Clin Exp Immunol; 1983 Nov; 54(2):595-8. PubMed ID: 6360441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal diagnosis of chronic granulomatous disease.
    Matthay KK; Golbus MS; Wara DW; Mentzer WC
    Am J Med Genet; 1984 Apr; 17(4):731-9. PubMed ID: 6720741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staining of eosinophils with nitroblue tetrazolium in patients with chronic granulomatous disease.
    Roberts RL; Ohno Y; Gallin JI
    Pediatr Res; 1986 Apr; 20(4):378-80. PubMed ID: 2422626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skewing of X-chromosome inactivation in three generations of carriers with X-linked chronic granulomatous disease within one family.
    Köker MY; Sanal O; de Boer M; Tezcan I; Metin A; Tan C; Ersoy F; Roos D
    Eur J Clin Invest; 2006 Apr; 36(4):257-64. PubMed ID: 16620288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of chronic granulomatous disease.
    Curnutte JT
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):241-52. PubMed ID: 2839457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focus on FOCIS: the continuing diagnostic challenge of autosomal recessive chronic granulomatous disease.
    Yu G; Hong DK; Dionis KY; Rae J; Heyworth PG; Curnutte JT; Lewis DB
    Clin Immunol; 2008 Aug; 128(2):117-26. PubMed ID: 18625437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of the autosomal recessive forms of chronic granulomatous disease.
    Curnutte JT
    Immunodefic Rev; 1992; 3(2):149-72. PubMed ID: 1554499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation for chronic granulomatous disease: long-term follow-up and review of literature.
    Leung T; Chik K; Li C; Shing M; Yuen P
    Bone Marrow Transplant; 1999 Sep; 24(5):567-70. PubMed ID: 10482944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of chronic granulomatous disease in Turkish families.
    Köker MY; Sanal O; De Boer M; Tezcan I; Metin A; Ersoy F; Roos D
    Eur J Clin Invest; 2007 Jul; 37(7):589-95. PubMed ID: 17576211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new X-linked variant of chronic granulomatous disease characterized by the existence of a normal clone of respiratory burst-competent phagocytic cells.
    Woodman RC; Newburger PE; Anklesaria P; Erickson RW; Rae J; Cohen MS; Curnutte JT
    Blood; 1995 Jan; 85(1):231-41. PubMed ID: 7803797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phorbol myristate acetate induced oxidation of 2',7'-dichlorofluorescin by neutrophils from patients with chronic granulomatous disease.
    Hassan NF; Campbell DE; Douglas SD
    J Leukoc Biol; 1988 Apr; 43(4):317-22. PubMed ID: 3162510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.